Publikationen von H. Zorbas

Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K.: KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients. Chemistry & Biodiversity 5 (10), S. 2140 - 2155 (2008)

Zorbas-Seifried, S.; Jakupec, M. A.; Kukushkin, N. V.; Groessl, M.; Hartinger, C. G.; Semenova, O.; Zorbas, H.; Kukushkin, V. Y.; Keppler, B. K.: Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands. Molecular Pharmacology 71 (1), S. 357 - 365 (2007)

Zorbas-Seifried, S.; Hartinger, C. G.; Meelich, K.; Galanski, M.; Keppler, B. K.; Zorbas, H.: DNA interactions of pH-sensitive, antitumor bis(aminoalcohol) dichloroplatinum(II) complexes. Biochemistry 45 (49), S. 14817 - 14825 (2006)

Hartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K.: From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). Journal of Inorganic Biochemistry 100 (5-6), S. 891 - 904 (2006)

Zorbas, H.; Keppler, B. K.: Cisplatin damage: Are DNA repair proteins saviors or traitors to the cell? ChemBioChem 6 (7), S. 1157 - 1166 (2005)

Jakupec, M. A.; Arion, V.; Berger, W.; Wild, S.; Zorbas, H.; Keppler, B. K.: Novel antineoplastic complexes of bismuth(III), cerium(III) and lanthanum(III). European Journal of Cancer 38 (Suppl. Suppl. 7), S. S125 - S126 (2002)